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ABBREVATIONS 
 
AFB  - Acid fast bacilli 
AIDS  - Acquired Immunodeficiency syndrome 
AMS  - Altered Mental Sensorium 
ART  -         Antiretroviral therapy  
CM  - Crytococcocal Meningitis 
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CSF  - Cerebrospinal Fluid 
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HIV         - Human Immunodeficiency Virus 
HSV        - Herpes Simplex Virus  
NA          - Not Applicable 
PCR             - polymerase chain reaction 
PMNL       - polymorphonuclear leukocyte 
LP  - Lumbar Puncture 
SE  - Septic Encephalopathy 
TBM       - Tuberculosis Meningitis 
VSV              - Varicella zoster virus 
ZN Stain - Ziehl -Nielsen Stain 
WBC        - White Blood count 
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INTRODUCTION 
  Acute febrile encephalopathy is clinical terminology used for 
altered mental status that follows short febrile illness characterised by  
diffuse nonspecific brain insult with clinical manifestations of coma, 
seizures and decerebration. This can be caused due to meningitis or 
encephalitis. Despite several epidemiological reports and investigations, 
the clinical presentation with acute fever and altered sensorium has often 
remained a mystery in south Indian state of Tamilnadu. Encephalitis is 
acute inflammation of brain parenchyma and presents as a diffuse or focal 
neuropsychological dysfunction and is almost always manifested with 
inflammation of meningitis. Acute febrile encephalopathy is commonly 
caused by viral infection. The diseases is also caused by bacterial and 
protozoal infection. 
  
  
 
AIMS  
AND  
OBJECTIVES 
  
2 
AIM & OBJECTIVES 
 To identify the etiology, clinical features, diagnosis and 
prognosis in patients with acute febrile encephalopathy above 13 years of 
age in a tertiary government general hospital in southern east India. Acute 
febrile encephalopathy is a important cause of morbidity and mortality in 
hospitalised patients with high mortality in undiagnosed or  untreated 
patients. Various etiological causes such as viral encephalitis, cerebral 
malaria, bacterial meninigitis, fungal meningitis implicated in the 
etiology according to geographical location. A study was conducted in a 
tertiary centre at Rajiv Gandhi general Government hospital, Chennai 
Tamilnadu on etiology, clinical features and prognosis in patients  
presenting with acute febrile illness with encephalopathy. 
 Following investigation were done during the study period for 
the patients. Haemoglobin, total leucocyte count, differential leucocyte 
count, platelet  count, peripheral blood smear,renal function test, serum 
electrolytes, dengue, widal test rapid diagnostic test for malarial parasite. 
Blood culture and urine culture were collected and any obvious site if 
sepsis was identified. Lumbar puncture was done in all of the patients and 
cerebrospinal fluid analysis for cytology, cell count, glucose, blood 
glucose ratio, gram stain and culture sensitivity for microbes, serology for 
herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein bar 
virus, Japanese encephalitis virus. 
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STUDY DESIGN: 
 A detailed history and clinical examination including 
neurological examination were done in all patients. Clinical   examination 
included identification of maculopapular rashes, petechiae, purpura, 
vesicles, eschar, herpes labialis, lymphadenopathy, diarrhoea, vomiting, 
parotitis, myalgia, arthralgia.  
 Organomegaly, hypotension, shock. The investigation done in 
all patients included haemoglobin, blood counts, peripheral smear for 
malarial parasite Quatitative buffy coat for malarial (QBC) for 
plasmodium  malaria, histidine rich protein  based immuno 
chromatographic card test  was done for patients in whom peripheral 
smear was negative for plasmodium falciparum malaria who were 
suspectable for complicated malaria. Serological test for dengue, hepatitis 
A,B,E and human immunodeficiency virus (HIV) leptospirosis  antibody, 
blood culture and urine culture in sepsis cases and site of sepsis 
investigated. Cerebrospinal fluid examination for cytology, cell count, 
protein level, glucose level, gram stain, AFB stain, adenosine deaminase 
levels, India ink staining and culture and sensitivity. Chest x-ray, 
electrocardiography, ultrasonography of abdomen, electroencephalogram 
and constrast enhanced computerized tomography (CT scan) were done 
as and when required .Magnetic resonance imaging (MRI) of brain was 
done when required. Pyogenic  meningitis was diagnosed on the basis of 
polymorphonuclear leucocytosis in CSF or positive gram stain or positive 
culture an sensitivity of CSF. Cerebral malaria was diagnosed in patients 
with febrile encephalopathy with positive peripheral smear or QBC for 
plasmodium falciparum. Outcome was assessed after 1month of follow 
up after discharge from hospital using modified Rankin scale (MRS). 
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Computed  tomography (CT) brain  non contrast and contrast enhanced of  
was done for all patients as a baseline imaging modality with AFE to rule 
out contraindications for lumbar puncture to study morphological 
changes. Magnetic resonance imaging (MRI) scan was done in particular 
cases where tubercular meningitis and fungal meningitis suspected. 
Appropriate treatment given to patient and follow up and outcome was 
studied in the patient. Magnetic resonance spectroscopy (MRS) was also 
done in when required. 
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REVIEW OF LITERATURE 
Definition and classification: 
Acute febrile encephalopathy is fever less than 2 weeks duration with  
altered sensorium >12 hours with clinical manifestation of central 
nervous system infection. 
Febrile encephalopathy is with <1week with alteration of consciousness. 
Encephalopathy  is diffuse disturbance of brain function  with or without  
inflammation 
Meningitis refers to inflammation of the leptomeninges and CSF within 
the subarachnoid space of  the brain , spinal cord and the ventricular 
system. 
Meningoencephalitis refers to inflammation of meninges and brain 
parenchyma 
Encephalitis is dysfunction of brain associated with inflammation 
Acute encephalitis syndrome is defined as a person of any age at any time 
of year with acute onset of fever and atleast one of one of 
1.A change in mental status(confusion disorientation coma 
2.New onset of seizures(excluding simple febrile seziures) 
Bacterial / Pyogenic meningitis: Pyogenic bacteria detected on Gram 
stain or culture. 
Tuberculous meningitis:AFB detected on smears and/or mycobacteria 
grown on culture of CSF 
Aseptic mononuclear meningitis:no bacteria or fungi on microscopy or 
culture of CSF,with increased CSF WBC  
Meningitis:Meningeal inflammation 
Myelitis:Spinal cord inflammation 
Radiculitis:Nerve root inflammation 
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SEPTIC ACUTE ENCEPHALOPATHY 
 Clinical course of brain abscess ranges from indolent to 
fulminant clinical manifestations with most of the clinical features 
depending on the size and location of a space–occupying lesion within 
the brain and the virulence of the infected microorganism.  
 
SEPTIC ACUTE ENCEPHALOPATHY 
SEPTIC ACUTE ENCEPHALOPATHY 
Sepsis  Acute Brain Dysfuction . 
 Undiagnosed Complicated  Infection Of 
CNS 
Clinical Manifestation Classic  Triad Of Fever, Headache And 
Neurological Deficit Weakness, Fatigue To 
Confusion and Delirium  
Sepsis Patients Associated Increased Mortality  
CT SCAN in brain  abscess hypodense center with peripheral uniform 
ring enhancement, surrounded by variable 
hypodense area of edema 
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INFECTIOUS CAUSES VIRAL/ BACTERIAL ENCEPHALITIS 
INFECTIOUS CAUSES VIRAL 
ENCEPHALITIS 
INFECTIOUS CAUSES OF 
BACTERIAL ENCEPHALITIS 
Herpes  simplex type ,type 2 
Varicella zoster 
HSV 
Cytomegalovirus, CMV 
Epstein barr virus 
Arbovirus –japanese 
encephalitis,Dengue,chikungunya 
(mosquito borne) 
Rhabdoviruses-rabies (animal bites ) 
HIV 
HSV 
Meningitis 
Brain abscess 
Sepsis associated encephalopathy 
Leptospirosis   
(Infected  dirty water) 
Typhoid 
M.tuberculosis (TB ) 
Rickettsial (scrub typhus) 
Cerebral malaria 
 
 
HISTORY OF ACUTE FEBRILE ENCEHALOPATHY 
HISTORY CLINICAL FEATURES 
Fever with rashes 
Maculopapular 
Petechiae/purpura 
Vesicles 
Eschar 
Herpes labialis 
Respiratory symptoms H1N1 
Diarrhoea,vomiting Enteroviruses 
parotitis HIV 
EBV 
Myalgia,Arthralgia Dengue,leptospirosis,chikun gunya 
Cough,sputum tuberculosis 
Gum bleeding,melena Dengue 
 
 
 
VIRAL MENINGOENCEPHALOPATHY:
 Chronic symptoms lasting more than 
caused by viruses. 
Dengue(Break Borne Fever)
 
Dengue Serotypes 
 
Dengue Classical 
Dengue Haemorrhagic Fever 
Encephalopathy 
 
 
WHO CLASSIFICATION OF DENGUE VIRUS
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1 week  suggest 
DENGUE ENCEPALOPATHY 
 Single Stranded RNA
Flavivirus
Den-1 To Den 4 
Are Heterogenous 
Endemic In Many Countries
Bite Of Aedes Mosquito 
Fever,Malaise,Headache 
Retroortibal Pain,Severe Myalgia, 
Arthralgia Face,Neck,Chest Er
Maculopapular Rash 
Cerebral Anoxia 
Cerebral Edema 
Cerebral Haemorrhage, Hyponatremia,
Hepatic Failure Toxicity 
NS 1 Antigen 
Dengue Igm antibody-5th
 
meningitis 
 Virus Of 
 
 
ythema 
 
 day 
 
 
Who classification of  Dengue fever
CRITERIA FOR DENGUE & WAR
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NING SIGNS
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DENGUE SHOCK SYNDROME 
DENGUE CLINICAL MANIFESTATION 
Uncomplicated  Dengue Fever Fever, Dehydration,Headache 
Dengue  Haemorrhagic Fever Results Due To Secondary Infection .Vascular  
Leak , Coagulopathy  Lead To Easy Brusing 
Bleeding Generalised Petechiae. 
Haemoconcentration,Serous Effusion  
And Hypoproteinemia 
Dengue Shock Syndrome And 
Encephalitis 
Multisystem Dysfunction In Severe Dengue 
Infection, 
Thrombocytopenia 
 
Dyselectrolytemia  
Shock Dehydration 
LiverDysfunction (Thrombocytopenia Or Coagulopathy 
Cerebral Hypoperfusion   
Neurogenic C Shock 
CerebralEdema  Due To Vascular Leakage  
Dengue Encephalopathy 
 
PATHOPHYSIOLOGY IN DENGUE ENCEPHALITIS 
 In recent times dengue encephalopathy is well recognised and 
common entity as a cause for acute febrile encephalopathy in patients 
presenting with thrombocytopenia. Increased intracranial bleeding  
(thrombocytopenia or coagulopathy). There is a increasing evidence in 
dengueviral neurotropism.Dengue neurotropism is a mechanism  as 
patients with dengue IgM antibodies. 
Dengue Haemorrhagic
Clinical Features  
Diagnosis 
Dengue Encephalopathy
 
SEROLOGICAL 
VARICELLA ZOSTER ENCEPHALITIS 
 VZV belongs to the herpesviridae family  with 3  subfamilies  
α,β,γ herpesviridae  with 
lymphotropic. α-βvirus herpesvirus
simplex virus. 
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 Fever Acute Febrile Illness 
Dehydration, Thrombocytopenia With 
Altered Sensorium, Bleeding 
Melena, Hypotension, Shock, 
Headache, Altered Sensorium
IGM Serology Was Positive
 Lethargy To Overt Delirium
VARIATION OF DENGUE
 
α-herpesvirruses neutrotropic and 
 VZV and is related clos
 
Gums, 
 
 
 
 
 
β, α are 
ely to herpes 
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VARICELLA ZOSTER VIRUS INFECTION  CLINICAL 
MANIFESTATIONS 
TWO CLINICAL FORMS OF VARICELLA ZOSTER MANIFESTATIONS 
Primary infection varicella 
(chicken pox ) 
Characteristic vesicular lesion in different stages of 
development on the face trunk and extremities  
Herpes zoster (shingles ) 
Reactivation of the endogenous latent  VZV 
infection in the trigeminal sensory ganglion. painful 
unilateral vesicular lesion in the particular  
dermatomal distribution herpes labialis 
 
          In addition to subclinical reactivation of the viruses, subclinical 
reinfection that boosts the immune response also occurs. Neurological 
complications caused by VZV occurs in both primary and reactivated 
VZV both central and peripheral nervous system are affected CNS 
complications in chicken pox are most commonly cerebellitis, 
encephalitis. 
THE NEUROPATHOGENEIS  OF VZV INFECTION 
Primary infection with  VZV   
Lateny  
 
Reactivated diseases 
 
Spread of virus  
 
Afferent fibres of trigeminal 
ganglion 
 
Transaxonal transport 
 
Vasculopathy 
Myelopathy 
Postherpetic neuralgia 
Retinal necrosis 
Cerebellitis 
Hamatogenous spread by T-cell mediated transport 
 
Transaxonal transport 
 
 
Afferent fibres innervating the afferent fibres 
infected 
 
 
 
Middle cerebral artery innervated by trigeminal 
ganglion is affected  
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Most Cranial Nerve Palsies  
Occur 
Most Have Complete Recovery 
Trigeminal  Nerve  Is The Cranial  
Most Commonly  Affected In VZV 
Reactivation 
The Optic Nerve,The Maxillary Nerve And The 
Mandibular Nerve Optic Nerve  Ocular  
Disorders, Retinal Necrosis. 
Ramsay Hunt Syndrome 
Peripheral Facial Palsy Accompanied By Rash 
On The Ear (Zoster Oticus),The 
Vestibulocochlear Nerve If Involved Commonly 
Reyes  
Syndrome 
Disease With Encephalopathy And Liver 
Damage  Associated  
With VZV Infection And Aspirin Intake 
Cerebellitis Completely Recovers Although Persistent Cerebellar Deficits  Such As Cognitive Defects   
Herpes  Zoster Induced Encephalitis  
(Adults) 
Residual Neurological Sequelae Common 
Increased Mortality Rate About 35% Without 
Treatment Neuropsychological Deficits - 
Subcortical Slowing Of Cognitive 
Process,Memory Impairment, 
Emotional,Behavioural Changes May Occur 
After A Latent Period  Of 10 Yrs After Acute 
Infection. 
  
In adults developing herpes zoster induced encephalitis  residual 
neurological sequlae is common with increased mortality rate. Without 
treatment neuropsychological deficits such as subcortical slowing of 
cognitive process, memory impairment and emotional and behavioural 
changes may occur after a latent period of 10 yrs after acute infection. 
The Brain imaging modalities CT scan shows multifocal lesions at grey 
white matter junction, both ischemic and haemorrhagic lesions. Anterior, 
middle cerebral arteries and internal, external carotid artery are most 
commonly involved. Meningitis, vasculopathy and radiculitis  are 
common. 
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HERPES SIMPLEX ENCEPHALOPATHY 
HSE  encephalitis   
Cause-HSV-1 in adults and HSV-2   in 
neonates. 
Commonly  affects Male:Female ratio:2:1. 
AGE Younger age group though older affected 
More common summer and rainy season 
Spread  
focal and severediseases causing  acute necrotising 
encephalopathy 
Onset Insidious or violent  
Common  
neurological 
manifestations 
Altered  sensorium ,seizures abnormal behaviour  
focal neurological deficit , ataxia, aphasia ,visual 
field defects , papilloedema. 
 abnormal behaviour, marked cognitive 
impairment.  
CSF  analysis Mononuclear  pleocytosis, Raised proteins   
Diagnosis  Serology test for HSV antibody in blood and CSF 
CT scan Bilateral asymmetrical frontotemporal lesion 
MRIscan 
bilateral asymmetric frontotemporal lesion and 
isolated temporal lesions 
EEG  
 
periodic lateralised epileptiform discharge (PLEDs) 
in the form of spike/sharp waves or slow waves 
from temporal lobe localization 
Differential diagnosis 
 Herpes Simplex Encephalitis (HSE) 
Cerebral Vein Thrombosis ,Cerebral Malaria, 
Tubercular  Meningitis,  
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PATHOGENESIS OF HERPES SIMPLEX VIRUS 
HERPES SIMPLEX VIRUS HSV 
HERPES VIRIDAE FAMILY, ENVELOPED.,  
DOUBLE-STRANDED  DNA VIRUS 
Viral infection begins at 
point of entry  
Oral  mucosa 
Genital mucosa 
Ocular conjunctival 
Virus replicates locally  
 
Tissue  damage 
 
Inflammatory response presents asvesicles ulcer 
 
HERPES SIMPLEX ENCEPHALITIS DIAGNOSIS 
HERPES SIMPLEX ENCEPHALITIS DIAGNOSIS 
CSF analysis 
WBC:  20-300cells /mm3 
Protein: 30-2500mg/dl 
Glucose : Normal 
EEG: spike an slow wave activity from temporal lobe.sensitivity 
85%specificity 33% 
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TREATMENT OF VIRAL ENCEPHALITIS 
TREATMENT OF VIRAL ENCEPHALITIS 
Acyclovir  IV 10mg/kg TDS 
14 to 21 days course for confirmed HSE 
Monitor renal functions 
Antiobiotics if CSF analysis and imaging modalities delayed 
Management of complications 
 
ACUTE HEPATIC ENCEPALOPATHY 
 Acute hepatic encephalopathy in acute liver failure due to acute  
hepatitis failure (ALF) which clinically manifests as jaundice, 
coagulopathy and encephalopathy.  
 Hepatitis A virus is one of the common causes of Acute liver 
failure (ALF) in children and young adults besides Hepatitis B, D, E, 
Though Hepatitis A in common in children the possibilities of fulminant 
complications arises with age, peaking above age of 40yrs. Hepatitis A is 
a self limiting in most case though some present with fulminate hepatic 
failure. In ALF massive hepatocellular necrosis leads to Jaundice, 
coagulopathy and encephalopathy. ALF patients most of the patients 
recovered with only supportive therapy and adequate hydration. Acute 
hepatitis A virus infection was also cause of acute febrile encephalopathy 
in our study in 4% cases. 
HIV-HUMANIMMUNODEFICIENCY VIRUS  
 HIV is the most common infection affecting the  central nervous 
system. Upto 50% of HIV patients have clinically apparent neurological 
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diseases. 20% present first time with neurological manifestations.10 % to 
15 present with only neurological symptoms. India has the second largest 
burden of HIV related pathology. Tamilnadu has the second largest 
burden of HIV related diseases .Neurological complications associated to 
HIV-1 infections are very common. The neuropathogenesis of HIV 
infection is direct HIV virus and its products or indirect opportunistic 
infections, HIV associated Neoplasms. Cells affected by HIV are 
perivascular macrophages, monocytes from blood, microglial cells and 
astrocytes 
NEUROLOGICAL MANIFESTATIONS OF HIV INVOLVING 
THE BRAIN 
Dementia  HIV Encephalopathy 
Progressive multiple Leucoencehalopathy (viral) 
Tuberculosis 
Infective 
granulomas 
Toxoplasmosis, 
Crytococcus 
Tuberculosis 
 
CLINICAL STAGING OF HIV ENCEPHALOPATHY 
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CYTOMEGALOVIRUS  ENCEPHALITIS 
 Cytomegalovirus is a double stranded linear DNA virus. 
Immuno competent host with CD4 counts < 50/cmm less than 2% of HIV 
infected patients develop CMV neurological symptoms. Crytococcal 
meningitis: Encapsulated yeast cells of C.neoformans detected in CSF 
by India Ink stain, positive CSF or serum cryptococcus Ag test 
 
HIV ASSOCIATED CYTOMEGALOVIRUS ENCEPHALITIS 
HIV ASSOCIATED CYTOMEGALOVIRUS ENCEPHALITIS 
GIT Colitis,Esophagitis -,Diarrhoea,Fever And Abdominal Pain 
Cardiovascular Pericarditis, Myocarditis 
Renal Collapsing Focal Glomerulosclerosis 
Eyes Anterior uveitis –Iritis,Blurring Vision , Redness Of Eyes 
CNS Meningoencephalitis, Encephalitis Venticuloencephalitis, 
Radiculomyelopathy ,Peripheral Neuropathy In Less Than 1% 
Motor Deficit Localised Weakness Paraplegia Sensory 
Abnormalities Numbness, Hypoaesthesia, Paraesthesia, Dysaethesia, 
Disorientation, Confusion Apathy,Cranial Neuropathy,Nystagmus 
Transverse Myelitis 
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DRUG OF CHOICE, PROPHYLAXIS AND PROGNOSIS  IN HIV  
ASSOCIATED CYTOMEGALOVIRUS   ENCEPHALITIS 
 
HIV  ASSOCIATED CYTOMEGALOVIRUS   ENCEPHALITIS 
Drug of choice is     Intravenous ganciclovir   
Second line- foscarnet 
Oral  valganciclovir   Long  term prophylaxis                      
Highly active antiretroviral therapy 
therapy 
Prevent CMV reactivation by 
reconstituting immune system 
Prognosis         Without  antviral therapy mortality 
100%With  antiviral therapy 50% 
recover 
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NONVIRAL CAUSES OF INFECTIOUS ENCEPALOPATHY 
TUBERCULOSIS MENINGITIS 
                                    TUBERCULOSIS MENINGITIS (TBM) 
BACTERIA Mycobacterium tuberculosis  
PATHOGENICITY Due to chronic reactivation bacillemia in older adults,  
Immune deficiency caused by aging, alchoholism, malnutrition, 
Human Immunodeficiency virus. 
CNS COMPLICATION OF PRIMARY INFECTION. 
Tuberculosis Meningitis 
(TBM)  
Spillage Of Tubercular Protein Into Subarachnoid   
Space Produces Intense Hypersensitivity Reaction, Vasculitis   Leading 
To Thrombosis And Infarction 
Common  HIV-Related TB Cases. 
Meningitis Stroke  Syndromes Involving Basal Ganglia, Cerebral Cortex, Pons 
And Cerebellum 
Communicating 
Hydrocephalus 
Extension  Of Inflammatory Process To Basilar Cisterns Impedance Of  
CSF Circulation 
Clinical Manifestations Headache , Fever, Altered Sensorium, Vomiting , Focal Neurological 
Deficit, Anorexia, Weight Loss, Positive  Signs Of Meningeal 
Irritation, Other Cranial Nerve Palsy Facial Nerve, Hearing Loss 
,.Speech, Memory  Behaviour Disturbances ,Focal Signs – 
Hemiparesis,Sensory Impairment 
Ophthalmoscopy Choroid Tubercles 
Gold Standard Diagnosis Acid Fast Staining Of CSF  Bacterial Culture 
CSF Analysis Increased Protein >500 mg/dl  
Low Glucose < 30mg/dl 
Lymphocytic Pleocytosis > 500cells  
Increased WBC Count >500 mm3.  
CSF  Will Be AFB Smear Positive In 5% 
Culture Sensitivity  In 50% 
PCR for TB positive  
CT Scan 
Reliable Method For Diagnosis 
Of TBM 
Multiple Ring Enhanced  Lesions 
Basiliar Arachoiditis .Cerebral Edema ,Infarction, Vascular 
Enhancement,Ventricular Dilatation. 
MRI  Scan  
Antituberculosis Drugs (ATT 
Empirical Therapy   
First line drugs Isoniazid (5mg/kg/day)  
Rifampicin(10mg/kg/day) 
Pyrazinamide (25mg/kg/day) 
Ethambutol  20mg/kg/day)  
supportive measures (Corticosteroids, 
Anticonvulsants ,Mannitol) started within 24-48 hours of admission 
Treatment Of Complications Corticosteriods In The Form Of IV Dexamethasone (0.6-
1.2mg/Kg/Day In Three Divided Doses) X 7days Then Oral 
Prednisolone (2mg/Kg/Day In  Three Divided  Doses) Was Started In 
Patients With Hydrocephalus To Prevent The Progression Of 
Diseases,Ventriculoperitoneal Shunt For Hydrocephalus Liver 
Function Test Was Done Week- Detection Of  ATT Induced 
Hepatotoxicity. 
prognosis Delayed treatment-  high mortality and neurological complications. 
 
CLINICAL CASE DEFINITION OF TUBERCULOSSIS MENINGITIS
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ANTITUBERCULOSIS DRUGS 
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ACUTE BACTERIAL MENINGITIS 
ACUTE BACTERIAL MENINGITIS (INFLAMMATION  MENINGES 
& BRAIN ) 
Subarachnoid space surrounding  meninges (Bacterialinvasion) enclosing 
the brain and the spine. 
Infection andinflammatory response  
 Severe  life threating diseases  
 
 The CSF which acts as a "shock absorber" for the brain and 
central nervous systemflows within it. 
The three layers of the meninges: 
 The outer Dura mater 
 The Arachnoid membrane 
 The innermost Piamater. 
 Acute meningtitis (<1 day) duration  is almost always a bacterial 
meningitis. Bacterial meningitis is caused by the presence of bacteria in 
the cerebrospinal fluid. Bacterial meningitis if  not treated in time will 
cause damage to the meninges and central nervous system resulting in as 
partial or complete deafness (due to a sub-infection of the cochlea) and, 
particularly in younger victims, epilepsy or retardation. Bacterial 
meningitis remains untreated, leads to excessive damage to the brain or 
central nervous system. Symptoms of Bacterial Meningitis include fever, 
headaches, seizures, vomiting, impairment of consciousness and stiff 
neck and back. The most important symptom of bacterial meningitis for 
early recognition is that of stiffness of the neck on bending forward. 
23 
OVERVIEW OF BACTERIAL MENINGITIS 
TYPICAL PATHOGENS INVOLVED IN BACTERIAL MENINGITIS 
Neisseriameningitides,Streptococcus 
pneumonia Hemophilus influenzae Most common pathogens 
 
Staphlyococcus aureus,Staphlyococcus 
epidermis,(Various other Streptococci) 
Escherichia coliKlebsiella 
enterobacter,ProteusPseudomonas 
Pathogens associated with 
complications due to Medical 
procedures on the nervous system such 
as neurosurgery, lumbar punctures, 
spinal anaesthesia and cranial trauma 
 
Salmonella,Shigella,Clostridium 
perfringensNeisseria gonorrheae Rare meningeal pathogens 
 
Listeria monocytogenes  Mainly occurs in  elderly>65 yrs age  
 
 
BACTERIAL MENINGITIS 
Pathogenesis: Three Major Pathways Exist By Which An Infectious Agent 
Bacteria, Virus Or Fungus  Gain Access To The CNS From The Site The 
OrganismInvades The Submucosa  By Circumventing Host Defense 
Mechanisms. 
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COMMON ORGANISMS OF  BACTERIAL MENINGITIS ROUTE ENTRY 
 Organism       Mode of Entry 
 
 
 
 
 
 
 
 These bacteria have a common mode of invasion into human 
body. Many are present on or in healthy humans as commensals, either on 
the skin or in the respiratory tract and as a result of trauma or weakness in 
the immune system invade the human body via the bloodstream. The 
bloodstream is their main route of infection to the meninges and 
cerebrospinal fluid. Once the bacteria enter the subarachnoid space  
intense host inflammatory response is triggered by lipoteichoic acid and 
other bacterial cell wall products. Bacterial meningitis can result from 
infections of the respiratory system, medical procedures, trauma to the 
nervous system or injury to the cranial region. 
 They result from infections of the upper respiratory tract or 
lungs (pneumonia  leads to pneumococcal infections of the meninges). 
The type of bacteria responsible forparticular cases of meningitis is also 
dependent on age as detailed in the table below, 
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ETIOLOGY OF BACTERIAL MENINIGITIS  WITH  AGE  VARIATION 
BACTERIAL MENINIGITIS  WITH  AGE  VARIATION 
BACTERIA NO. OF CASES IN ADULTS AND CHILDREN 
Neisseria meningitidis 10-30% in adults, 30-40% in children up to the  
age of 15 
Streptococcus 
pneumonaie 
30-50% in adults, 10-20% in children 
Hemophilus influenzae 1-3% in adults, 35-45% in children 
Listeria monocytogenes Infants and elderly age group 10% 
 
PNEUMOCOCCUS 
Pneumococcus Separate , paired or short chains of oval-shaped cocci,  
Cells enclosed by a polysaccharide envelope 
Blood cultures  Pneumococci stain gram positive 
Pathogenicity Lobar  pneumonia , Pleural,Empyhsema, Pericarditis, 
Endocarditis, Arthritis, Peritonitis. Middle  ear infection 
(Cochlea) Bacterial meningitis (Hematogenous spread) 
 
Penicillin therapy reduces high mortality due to 
pneumococcal infections. 
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MENINGOCOCCUS (NEISSERIA MENINGITIDIS) 
Meningococcus Diplococcus Aerobic Bacteria Gram Negative Stain.Two  Main 
Serogroups A And C Of Meningococcus  Cause Epidemics . 
Humans Are  Only Natural Host Of The Meningococcus . 
Mortality  Is  High In Cases Of Meningitis Caused By 
N.Meningitidis, Due  To Rapid Release Of Large Amounts Of 
Bacterial Endotoxin Into Bloodstream Which Results In Toxic 
Shock And Hemorrhage In The Affected Areas. 
 
HAEMOPHILUS (HEMOPHILUS INFLUENZAE) 
(Hemophilus influenzae) Obligate parasite, commonly live in the upper respiratory 
tract, lower genital tract, mouth and pharynx of humans. 
Clinical manifestations Bacterial meningitis, in young infants. conjunctivitis, 
Infection  of the middle ear and secondary infections of 
the respiratory tract. 
Haemophilus infections Ampicillin most prevalent form of treatment. 
But as a result of developing resistance to this drug, 
Chloramphenicol and Tetracycline are more suitable and 
effective. 
 
MICROBACTERIAL THERAPY FOR ACUTE BACTERIAL MENINGITIS 
Haemophilus inflenzae type B  3rd  Generation cephalosporin 
Neisseriameningitidis   Penicillin  or Ampicillin  
Streptoccus pneumonia               Vancomycin plus 3rd  generation 
cephalosporin 
Listeria monocytogenes Ampicillin   or Penicillin   
Streptococcus agalactiae Ampicillin   or Penicillin  
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LEPTOSPIROSIS 
Leptospirosis ( Hemorrhagic Jaundice) 
Acute AnthropicZoonosis Infection 
Cause Spirochaete Leptospira Interrogens 
Common Victims Agricultural  Occupational Workers 
Principle Source Of  Infection. Rats, Dog, Swine, Cattle 
Infection Source  Leptospira  Present In Water 
Entry Into Body Mouth-Nose, Conjunctiva ,Breaks In Skin 
Incubation Period 7-13 Days 
Leptospirosis Acute Severe  Form Weils Disease- Jaundice. Meningitis, Hepatitis, 
Nephritis,Rash And Produces Haemorrhage 
And Necrosis, Headache Neck Stiffness 
Continous Fever, Stupor, Coagulopathy Anemia 
In 3-6 Days Liver / Kidney - Infection 
Progressive, Fatal Septicemic Failure 
Confirmatory  
Serological Test For Diagnosis 
Microscopic AggutiationTest (MAT) 
 
Other Test For Diagnosis Serology Ellisa-Raised Igm Titers Positive 
Earlier Than MAT. PCR-Based DNA 
Fingerprinting Methods Available For 
Diagnosis 
CSF Analysis Pleocytosis 
 
WEILS DISEASES CLINICAL MANIFESTATIONS  AND COMPLICATIONS 
Clinical features Complications 
Altered  sensorium Meningitis  
Acute kidney failure-nephritis Azotemia,oliguria, dysuria   
Myocarditis and hypotension Coagulopathy  
Pulmonary haemorrhage-haemoptysis-
respiratory failure 
Hepatorenal  failure  
Acute hepatic failure-hepatitis Gastroinstestinal bleed 
Lymphadenopathy Hepatosplenomegaly 
Pancreatitis 
Jaundice  
Purpura Thrombocytopenia , Anemia 
Conjunctival effusion,heamorrhage Chorioretinitis  
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TREATMENT OF LEPTOSPIROSIS 
TREATMENT OF LEPTOSPIROSIS 
Drug of choice Benzyl penicillin  5 mega units in a day for 
5 days 
Hypersensitive to  penicillin Erythromycin 250mg QID for 5 days 
Doxycycline 100mg BD for 7 days 
Tetracycline 500mg QID 
Ciprofloxacin 500mg BD 
Ampicillin and Amoxicillin are effective 
in the treatment. 
Chemoprophylaxis Doxycycline 200mg orally once weekly  
effective 
vaccine For 3 serotypes very effective 
 
PATHOGENESIS  OF  BRAIN ABSCESS 
MODE OF   
SPREAD 
PRIMARY SITE OF 
INFECTION 
SITE OF BRAIN 
ABSCESS 
Haematogenous 
Spread   
Lung Abscess, Empyema, Skin 
Infection Pelvic Infection  
Intra abdominal Infection, 
Bacterial Endocarditis, 
Cyanotic Congential Heart 
Diseases 
Any Site Affected 
Direct 
Transmission 
Frontal Ethmoidal Sinusitis Frontal Lobes  
 Subacute Chronic Otitis 
Media,Mastoiditis 
Inferior Temporal Lobe 
Cerebellum 
 Dental Infections Frontal Lobes 
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CRYPTOCOCCUS MENINGITIS 
CRYPTOCOCCUS MENINGITIS 
Cryptococcus 
meningitis   
Major   fungal meningitis  in HIV related  
opportunistic  infection.,10% of  AIDS population. 
Most common Life threating  infection of meninges mostly  
occurring in HIV patients with CD4 counts below 100 
Most patients 
exposed 
organism which is found in the soil  contaminated by bird 
droppings, does not cause diseases in healthy 
 
 
CRYTOCOCCAL MENINGITIS 
Clinical features   Fever, fatigue, nausea, vomiting, headache,  
confusion, personality changes  visual, hearing 
impairment,  progressive dementia 
Untreated cases Coma  and death 
Diagnosis Cryptococcal   antigen  in CSF  1% 
CSF culture for cryptococcus 95 % India ink positive 
Treatment Antifungal  drug amphotericin B 0.7mg/kg/day for 
2weeks  . Fluconazole is given daily   
prevents relapses. 
Alternative drug Flucytosine for 2 weeks. Fluconazole  oral or IV 
400mg qd for 6 weeks causes fewer  severe side 
effects   
including rashes and liver enzyme abnormalities 
Fluconazole 
Prophylaxis 
CD4 count below 50mm3 can help prevent  
crytococcal meningitis. long time can cause drug 
resistent 
Drug complications Starting while treating cryptococcal meningitis   
increased the risk of (IRIS) immune reconstitution 
syndrome 
HAART – Highly Active Antiretroviral Therapy, Iris-Immune 
Reconstitution Syndrome 
          Confirmed etiotlogical agent among adult HIV infected patients.  
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NEUROCYSTERCOSIS 
NEUROCYSTERCOSIS 
NEUROCYSTICERCOSIS      (NCC) 
MOST  COMMON PARASITIC 
DISEASE OF THE CNS AFFECTING 
PEOPLE ALL OVER THE WORLD 
COMMONEST  CAUSE  OF SMALL 
SINGLE ENHANCING CT LESION              
                       (SSECT) 
CAUSE  TAENIA  SOLIUM TAPEWORM 
INTERMEDIATE  HOST PIGS 
COMPUTED TOMOGRAPHY OF 
BRAIN 
OTHER  INFECTIONS CAUSING 
RING ENHANCED LESIONS ARE 
RING  ENHANCED LESIONS: 
CHARACTERISTIC  
NEUROCYSTICERCOSIS 
 
OTHER  INFECTIONS CAUSING 
RING ENHANCED LESIONS ARE 
TUBERCULOMA  
TOXOPLASMOSIS 
CRYPTOCOCCOSIS   
HISTOPLASMOSIS 
CANDIDA  ALBICANS 
VERY  SIMILAR TO 
TUBERCULOMA 
USUALLY SEIZURES, BUT FEVER 
ALSO CAN BE A PRESENTATION IN 
RARE CASES CLINICAL 
PRESENTATION 
CLINICAL MANIFESTATION 
SEIZURES, HEADACHE ALTERED 
SENSORIUM, MULTIPLE 
NONTENDER NODULAR 
MRI 
PUNCTATE ECCENTRIC HIGH 
DENSITY STRUCTURE IS 
PATHOGNOMONIC FOR DIAGNOSIS 
EXTENSIVE PARENCHYMAL NCC 
(STARRY SKY APPEARANCE) 
MOST COMMON SITE IN BRAIN 
PARENCHYMA 
CORTICOMEDULLARY JUNCTION 
NCC- NEUROCYSTERCOSIS, ,SSECT SMALL SINGLE ENHANCING CT LESION 
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TREATMENT OF NEUROCYSTICERCOSIS 
Mainstay treatment  symptomatic  
Specific Antihelminthic   Aldendazole 15mg/kg for 4 weeks 
 Praziquental-50mg/kg for 15 days  
Anticonvulsants   Seizures  
Cerebral  odema or 
vasculitis 
 Corticosteriods 
Surgical treatment  Hydrocephalus  Gaint cyst ( >10cm)  with 
intracranial hypertension  
 Cyst  in  fourth ventricle  
 Cyst attached to middle cerebral artery 
(MCA) 
 CSF diversion in obstructive hydrocephalus 
 
TUBERCULOMA VERSUS GRANULOMA 
TUBERCULOMA NEUROCYTICERCOSIS 
 Usually Large 
>20mm,Multiple 
 Smaller< 20mm May Be Single Or  Multiple 
 Severe Perifocal Oedema 
With Focal Neurological 
Deficit 
 Cerebral Oedema No Midline Shift Or Focal 
Neurological Deficit 
 MRI:Ring Enhanced Lesions  MRI - A Punctate Eccentric High Density 
Structure Suggestive Of Scolex - 
Pathognomonic For Diagnosis.(44%) 
 Multiple  Ring Enhanced Lesions 
 More Common In Posterior 
Fossa  
 More Common At Grey- White Junction 
 MR Spectroscopy Shows 
Lipid Peaks With 
Tuberculoma 
 Ocular Manifestation ,Muscle Involvement Or 
Subcutanous Nodules 
 Clinical Features Of TB Else 
Where –Lungs,Lymph Nodes 
 Spontaneous Resolution Eventual Calcification 
More Common In NCC 
 
 
 
DIAGNOSTIC CRITERIA USED FOR DIFFERENT ETIOLOGIES OF 
ACUTE FEBRILE
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 ENCEPHALOPATHY
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RABIES ENCEHALOPATHY 
RABIES   - HIGHLY FATAL DISEASE OF CNS CAUSE- LYSSAVIRUS TYPE 1 
Rabies Virus Lyssavirus –Type 1,Bullet Shaped Virus 
Transmission Route  Bites Of Rabid Animals 
Most Common  Affected   Young Adults 
Affinity Binding To Acetylcholine Receptors In Neural Tissue 
Pathogenesis Street Virus Found In Saliva Of Infected Animal Especially Dogs  
Reservoir Of Infection Dogs And Cats 
 
All Warm Blooded Animals Including Man Are Infected Rabies Is 
A Dead End  
People At Risk Lab Workers,Veterinarians,Dog Handlers,Hunters,Etc  
Mode Of Transmission Animal Bites,Licks,Aerosol,Person To Person. 
Incubation Period    
Depends On  Severity Of Bite 
Number Of Wounds 
Amount Of Virus Infected 
Species Of Biting Animal 
Protection Provided By Clothing   
Treatment Taken. 
Incubation Period 5 Days -6 Months 
Common Affected 
III,IV And Ixth Cranial  
Nerve Palsies Most Common  
Clinical Manifestations In 
Man   
Bizarre  Behaviour, Agitation, Seizures, Difficulty In Drinking 
Headache, Fever, Sorethorat , Nervousness, Confusion, Pain  Or 
Tingling At The Site Of The Bite , Hallucinations, 
Hydrophobia,Spasms Of Pharynx Produces Choking, Respiratory 
Paralysis, Coma And Death In 1-6 Days. 
Neurologic Phase  
Encephalitic Rabies -80%  
Fever, Confusion, Hallucinations, Combativeness Muscle Spasms, 
Hyperactivity, Seizures. Autonomic Dysfunction Like 
Hypersalivation, Excessive, Perspiration, Gooseflesh, Pupillary 
Dilatation, Priapism, Hyperexcitability  
Followed By Periods Of Complete Lucidity ,Hydrophobia, 
Aerophobia, Foaming At The Mouth,  Dysfunction  Infected 
Brainstem- Severe Brainstem Damage,Coma, Death, Paralytic 
Rabies-20% Complicated Encephalitis , I Water Balance 
Disturbance, Cardiac Arrhythmia, Myocarditis. 
 
  
TYPES OF CONTACT CATEGORY IN  RABIES
PATHOGENESIS OF RABIES ENCEPALOPATHY
RABIES  POST EXPOSURE PROPHYLAXIS
RABIES  POST EXPOSURE PROPHYLAXIS
Rabies Immunoglobulin (RIG)  single dose 20IU per kg of body weight  indifferent 
parts of body  and  at site of bite and antirabies vaccination (RAPUR)intramuscular 
dosed of 1ml or 0.5ML  given as  0,3,7,14,30  dose
Abbreviated multisite schedule 2
arm on day 0 one dose on the deltoid muscle on days 7 and 21, the 2
post exposure rabies immunoglobin is not given
Local treatment of wound , T
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-1-1 regimen,one dose right arm,one dose in the left
 
etanus  toxoid  vaccination 
 
 
 
 
 
 
 
-1-1 schedule.if 
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PROGNOSIS IN RABIES VIRUS WITH 100% MORTALITY 
 
SCRUB TYPHUS ENCEPHALOPATHY 
 Due to rapid urbanization of rural and forested areas scrub 
typhus has become an emerging public health problem in India. Scrub 
typhus is a  etiological factor for AFE, resulting in significant morbidity 
and mortality. Most common in patients from Tamil Nadu and Andhra 
Pradesh.       
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SCRUB TYPHUS ENCEHALOPATHY 
Scrub Typhus (Bush Typhus) 
Cause Orientia Tsutsugamushi   Is A  Zoonotic  Disease 
Pathogen  ObligateIntracellular Gram Negative Bacterium 
Age Group 35-62 Years 
Clinically  Presents 
Fever, Headache, Inoculation Eschar, And 
Lymphadenopathy. 
Characteristic  Eschar  Presence  
Severe Form 
Manifestation 
Pneumonia, Myocarditis, Azotemia, Shock, Gastrointestinal 
Bleed, And Meningoencephalitis 
Central Nervous System 
Manifestation 
Acute  Encephalitis Syndrome (AES) 
Complications  
After 1 Week Of Illness -Jaundice, Renal Failure, 
Pneumonitis, ARDS, Septic Shock, Myocarditis, 
Meningoencephalitis, Respiratory Failure , Septic Shock  
Results In Multiorgan Failure, DIC,Mortality 7-30% 
Diagnosis  
Weil-Felix Agglutination Test  Using Proteus OXK Strain  
Positive 50% During Second Week Of Illness 
Immunoglobulin  M Enzyme Linked Immuno-sorbant 
Assay Positivity 
CSF Analysis  
EEG Study   
Bilateral  Diffuse Cerebral Dysfunction With Epileptiform 
Discharges With No  Specific Lateralization. 
MRI 
Diffuse Cerebral Edema, Hyperintense Lesions In Putamen 
& Thalamus In T2-Weighted & 
Fluid-Attenuated Inversion Recovery (Flair) Images. 
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TREATMENT SCRUB TYPHUS ENCEPHALOPATHY 
DRUG of choice Doxycycline 100 mg twice daily for a  
period of 7-10 days. 
Inadequate response to 
doxycycline 
Azithromycin  given 
Multi-organ dysfunction 
syndrome (MODS) (>2 organ 
involvement) 
Multidisciplinary intensive care including  
ventilatory support and dialysis 
 
JAPANESE ENCEPHALITIS   
JAPANESE ENCEPHALITIS 
Japanese Encephalitis 
Zoonotic Disease Infecting Mainly Animals 
Incidentally  Infects Man. 
Japanese Encephalitis Virus (JEV) Mosquito Borne Flavivirus 
 Virions - Spherical,Lipoprotein-Enveloped.Genome - Single 
Stranded Positive Sense RNA 
Transmitted Arboviruses (Abv) Endemic InTemperate And Tropical 
Asia.Epidemic In India 
Domestic Animal Of JE Horses Dead End Host 
Amplifers  Domestic Pigs Virus Producing High Viremia Which Infect 
Mosquito Vectors 
Reservoir  WildBirds Like Heron And Egret 
Trasmission Of Je Virus 
Mosquitoes Principle Vector 
 
Culex  Tritaeniorhynchus (Oviposits In Flooded Fields (Fish 
Ponds, Rice  
Paddies And Ditches) 
India  Vector. Culex  Vishnui 
Incubation Period 5 -15 Days 
Pathogencity  Virus Multiplies At The Site Of Bite And In Regional 
Lymphnodes  Viremia Spreads.   
Neurological Disease  
 
Life Threating Encephalitis,  
< 1% Cases  Neuroinvasive Disease  
 Severe  High Case Fatality Rate 
Diagnose CSF Analysis Je Igm Antibodies 
Prevention Preventive Measures  Adapted  By Travellers Going To JVE 
Epidemic Areas. 
TRANSMISSION CYCLE OF JAPANESE ENCEPHALITIS VIRUS
 Diagnosis 
considered in patients who have  returned from recent travel to JE 
epidemic areas. Disease is usually by serology
TREATMENT, CHEMOPROPHYLAXIS
Drug Of Choice  
Children Vaccination
Endemic Areas 
Prevention 
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of acute febrile encephalopathy JE should be 
 examination
 & PREVENTION IN JAPANESE 
ENCEPHOPATHY 
No Specific   Drug Available
 ≤ 15 Years In SA 14 -14-2 Japanese Encephalitis 
Vaccine Vaccination Children  
Avoid Mosquito Exposure By Using 
Bed Nets While Sleeping, Mosquito 
Repellants With Diethyltoluamide 
(DEET).Insecticides And Mosquito 
Killing Agents Should Be Used To 
Control Viral Spread, Larvivorous Fish 
Grown In  Draining Rice Paddies 
 
 
. 
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PATHOGENESIS OF JAPENESE ENCEPALITIS 
Japanese encephalitis  virus invasion into CNS 
 
Microglia (resident immune cells of central nervous system) 
 
Increased microglial activation 
 
Increased cytokine secretion 
(interleukin -1,tumor necrosis factor alpha ) 
 
Toxic effects on the brain 
 
Activated microglia secrete 
(Neurotoxins, excitatory neurotransmitters, reactive oxygen prostaglandin) 
 
STAGES IN COURSE OF JAPANESES ENCEHALITIS IN  HUMAN AND 
CLINICAL MANIFESTATION 
Three Stages In Course Of 
Diseases 
Clinical Manifestations 
1.Prodromal Stage (1-6 Days) Fever Headache Malaise 
2.Acute Encephalitic Stage Fever, Nuchal Rigidity,Focal Neurological 
Signs,Convulsions. Altered Sensorium 
Progressing  To Coma. 
3.Late Stage Of Sequelae Fever Subsides, Serious Residual Neurological 
Deficit-Paralysis, 
Brain Damage –Deafness, 
Emotional Liability, 
Hemiparesis 
Prognosis: Average Period Between Onset Of Illness 5days 
Death In About 9 Days 
Case Fatality Rate (CFR)  20-40% 
Humans - Mortality Rate 5-35%.  
Serious Neurologic Sequelae  33-50% 
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 CT scan shows oedema and congestion of brain and meninges, 
thalamus is severely affected. The differential diagnosis is meningitis, 
rabies, cerebral malaria, toxic encephalopathy 
INVESTIGATION 
LACTATE DEHYDROGENASE 
 Normally it is used in evaluation of many diseases conditions. 
LDH enzyme is found in all body cell and released into the  serum  when 
cells are damaged. LDH is thus a indicator of tissue and cellular damage. 
LDH also raises in other types of body fluids, the cerebrospinal and 
pleural fluid. In the presence of meningeal infections and diseases, like 
CSF to distinguish between viral, bacterial and fungal meningitis. LDH is 
evaluated in, If LDH is elevated more specific test like ALT, AST or 
ALP are further done to diagnosis  a particular diseases.  
LACTATE DEHYDROGENASE 
Lactate Dehydrogenase (LDH)  Nonspecific 
High Levels  Of LDH In 
Cerebrospinal Fluid   
Meningitis Is  Bacterial In Origin 
Low Or Normal Level Viral  
LDH Is Increased Sepsis, Acute Liver Diseases, 
Meningitis, Encephalitis HIV. 
LDH test is performed on body 
fluids 
Peritoneal, pleural, pericardial fluid, 
Cerebrospinal fluid (CSF) 
 
 
 
CSF LACTATE DEHYDROGENASE IN MENINGITIS 
CSF LACTATE DEHYDROGENASE IN MENINGITIS
>35µ/dl 
25-35 µ/dl 
>35 µ/dl 
 
CSF FINDING IN DIFFERENT TYPES OF MENINIGITS
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CSF  ANALYSIS 
Bacterial Meningitis 
Tubercular, Fungal Meningitis 
Viral  Meningitis 
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NEUROIMAGING  MODALITIES 
COMPUTERISED TOMOGRAPHY (CT SCAN) 
 The Most Important Need For 
CT Scan 
Rule  Out  Contraindication For Lumbar 
Puncture. 
Rule  Out Infection Otorhinologic Structures Infection- Sinusitis, 
Mastoids  To Locate Infection Causing  
Complications - Meningitis, Hydrocephalus, 
Subdural Effusion, Empyema, Cerebritis, 
Developing Abscess And Infarction 
 Exclude Parenchymal Abscess ,Ventriculitis 
Specific Findings In CT Scan  
Pyogenic Brain Abscess Ring Enhanced Lesion   
In Tuberculosis Tuberculoma   Multiple -Ring Enhanced 
Lesion Are Seen In CT scan  
 
 The diagnosis of acute bacterial meningitis should not be made 
on the basis of imaging studies alone. The diagnosis should rather be 
established by the affected patients history, physical examination findings 
and laboratory results of  which lumbar puncture and CSF analysis is a 
the single most important  diagnostic study. CT scan may reveal the cause 
of meningeal infection. Obstructive hydrocephalus occur in  
inflammatory changes in the subarachnoid space or ventricular 
obstruction. In acute meningitis CT scan may be normal  in early stages 
of encephalopathy.  So the results of an imaging   scan do not exclude or 
prove the presence of acute meningitis. Computed tomography (CT) brain  
non contrast and contrast enhanced of the brain  was done for all patient 
who presented with acute febrile encephalopathy.   
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MAGNETIC RESONANCE IMAGING (MRI) 
 Nonspecific Changes Meningeal  Enhancement  Nonspecific  
Infections, Carcinomatous 
Meningitis. Reactive Meningitis, 
Inflammatory  Conditions  Sarcoidosis  
Collagen Vascular Diseases.  
Magnetic Resonance Imaging 
(MRI) Scan 
Detection Of Meningitis Complications  
Like Hydrocephalus, Cerebritis, Abscess, 
Cranial Nerve Lesions, Thrombosis, 
Infarction, Ventriculitis, Vasculopathy. 
DENGUE Encephalitis  Bilateral Hyperintensities On Flair 
Sequences In Thalami (FLAIR Sequences) 
Magnetic Resonance Spectroscopy  Useful To Distinguish An Abscess  
From Other Ring Enhancing Lesion-
Tuberculoma, Neurocytisercosis, Glioma, 
Fungal  
 
 
  
  
 
MATERIALS  
AND  
METHODS 
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MATERIAL AND METHODOLOGY 
 All patients above the age group of 13 years to 65 yrs who 
presented to the hospital with acute febrile encephalopathy with 
neurological manifestations and admitted in the department of medicine 
at Rajiv Gandhi hospital with fever of less than two weeks duration along 
with altered sensorium with or without seizures were enrolled in the study 
from March 2014 to July 2015. A prospective study was done  from 
August 2014 to August 2015.a total of 100 case with acute  febrile 
encephalopathy. 
INCLUSION CRITERIA: 
 All children above the age of 13 years and all adults upto 65 
years. Patients who presented to the medicine department with acute 
febrile illness with less than 2 weeks duration with any of the following  
clinical  neurological manifestations of alteration of consiousness level, 
headache, disorientation, vomiting, focal neurological deficit, blurring of 
vision and with  diarrhoea, vomiting chills rigors were enrolled in the 
study group. A total of 100 patients were taken for study. 
EXCLUSION CRITERA : 
 Patients  with non-infectious causes of unconsciousness  who 
presented with Traumatic brain  injury, chronic encephalopathy, Vascular 
(vasculitis, SLE, SAH, SDH, stroke, behcets) with past history of 
neurological disorders like seizures and in whom persistent altered mental 
status could be attributed to dearrgened Metabolic (hepatic  renal failure 
,diabetes) encephalopathy with  metabolic parameters as hypoglycemia 
<50mg/dl , hypoxia (pao2 <60mmHg), hypercapnia (pco2 >50mmHg) 
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Dyselectrolytemia  with hyponatremia (<120mg/dl) hypernatremia 
(>150mg/dl ) space occupying lesion (SOL) or endrocinopathies like 
addison’s, hypothyroidism hashimotos encephalopathy, Toxic (alcohol, 
drugs) encephalopathy patients were excluded from the study. Patient  
with previous psychiatric illness or previous drug treatment for any other 
neurological disorders were  excluded from  the study. 
DEMOGRAPHY AND HOSPITAL STAY. 
 A total of 100 patients of the age group above 13 years  were 
included in the study in which 50% were below 35 yrs of age .Males were 
common commonly affected. Male:female Ratio 2:1. 
Patients admitted earlier with less clinical manifestation had good 
recovery and recovered after intensive treatment. For a duration of 7days 
or 14 days. patients who presented to the hospital after  severe 
manifestations of Acute febrile encephalopathy and fever for more than a 
week duration had a longer course of treatment in the hospital in the 
intensive care unit and complications like acute liver  failure was 
controlled in most patients. Patients with complications like acute 
respiratory distress, aspiration pneumonitis and disseminated 
intravascular coagulation would not be  treated and mortality was high in 
these patients. 
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IDENTIFICATION OF COMPLICATING SIGNS IN ACUTE 
FEBRILE ENCEPHALOPATHY 
Identification of deteriorating  signs in Acute Febrile 
Encephalopathy 
Seizures  
Shock  
Sepsis  
 
Raised ICT 
Papilledema 
Asymmetric pupils 
Posturing 
Absent Dolls eye movement 
 
MANAGEMENT OF PATIENT WITH ACUTE FEBRILE 
ENCEHALOPATHY GCS<15 
Assessment Oxygen  therapy Monitoring  
 
 Airway  
 Breathing   
Circulation  
 Disability   
 
If respiratory rate increased and 
inadequate for ventilation 
Ventilation  
O2 saturation <92% despite high 
flow O2 through venturi mask 
If GCS < 8 
Signs of raised intracranial 
pressure Signs of shock despite 
fluid management 
Heart rate 
Respiratory rate 
O2 saturation 
Blood pressure 
Temperature 
ECG (hourly recorded or 
continuously monitored) 
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MANAGEMENT OF PATIENTS WITH RAISED 
INTRACRANIAL PRESSURE 
Management of patients with raised intracranial pressure 
Early intubation if GCS<8  
Head end elevation of 15 -30ο 
Avoid  hypotonic solutions 
Hypertonic saline -3% saline  in Hypotension 
Hypovolemia, serum osmolality >320mOsm//kg. Renal failure dose 0.1-
1mg/kg/hr 
Mannitol 20 % solution initial bolus 0.25-1g/Kg then 0.25-0.5g/kg,Q2-6h 
as requirement upto 48hours 
Hyperventilation –PaCO2 30-35mmHg 
 
EMPIRICAL TREATMENT OF  ACUTE FEBRILE 
ENCEPHALOPATHY 
EMPIRICAL TREATMENT OF  ACUTE FEBRILE ENCEPHALOPATHY  
IV  cefotaxime  2 gm  BD dose daily x 7 days 
IV  Acyclovir  500mg TDS daily  x 7days 
IV  Artesunate  120 mg  OD daily  x7 days 
Doxycycline  100mg oral  BD daily x 7 days 
Then after Investigations  Drug of choice continued or added 
Most of the patients with acute febrile encephalopathy completely 
recovered without any neurological deficit. once the underlying etiology 
is diagnosed and the patient in treated with appropriate antivirals, 
antibiotics or even with empirical  treatment. is. IV acyclovir is the 
treatment of choice for viral encephalititis. Respiratory complications like 
aspiration pneumonitis treated with higher antibiotic erythromycin, 
azithromycin, clarithromycin,  symptoms resolved over several days to  
2-3 weeks, Antibiotics are the most common form of treatment although 
some vaccines are available 
PROGNOSIS  
Prognosis was gra
neurological sequelae like cognitive impairment,
seizure seen in 5%.
the mortality rate. Most cases of Bacterial meningitis have good
prognosis provided the disease is diagnosed rapidly and treated 
appropriately. Condition such as alcoholism and high
reduce the chancesof a full recovery.
PROGNOSIS OF ACUTE FEBRILE ENCEPHALOPATHY
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ded according to Modified rankin score
 weakness, ataxia,
 The recent advent of newer antibiotics has reduced 
-dose steroid use  
 
 ACCORDING TO 
MODIFIED RANKIN SCALE 
 
. 
 
 
  
 
OBSERVATION  
AND  
RESULTS 
  
OBSERVATIONS AND RESULTS
AGE 
Up to 20 yrs
21-30 
31-40 
41-50 
Total 
 
 In our study 35% cases of acute febrile encepha
most common in age group between
 
 
35%
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Table 1: Age Distribution 
FREQUENCY PERCENT
 31 31.0
35 35.0
25 25.0
9 9.0
100 100.0
Chart 1 : Age Distribution 
 21-30 yrs 
 
31%
35%
9%
Age
 
 
 
 
 
 
 
lopathy were  
Up to 20 yrs
21-30
31-40
41-50
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TABLE 2 : SEX FREQUENCY 
SEX FREQUENCY PERCENT 
Male 59 59.0 
Female 41 41.0 
Total 100 100.0 
 
Chart 2 : Sex Frequency 
 
 
         Male patients were more common in our study group about 59% 
cases. 
  
59%
41%
Gender
Male
Female
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Table 3 : CLINICAL FEATURES IN ACUTE FEBRILE 
ENCEPHALOPATHY 
 
 Headache 55% and fever 40% were the most common clinical 
manifestations. neck rigidity 34%, altered sensorium, 37%, seizures 24%, 
focal neurological deficit 9 % was  least common  
Chart 3 CLINICAL FEATURES IN ACUTE FEBRILE ENCEPHALOPATHY 
   
 
 
 
 
 
 
 
CLINICAL FEATURES IN ACUTE 
FEBRILE ENCEPHALOPATHY 
FREQUENCY PERCENTILE 
Fever 40 40% 
Headache 55 55% 
Vomiting 10 10% 
Neck Rigidity 34 34% 
Altered Sensorium 37 37% 
Seizure 24 24% 
Focal Neurological  Deficit 9 9% 
40%
55%
10%
37%
24%
9%
0%
10%
20%
30%
40%
50%
60%
Fever Headache Vomiting Altered 
sensorium
Seizure Focal 
neurological  
deficit
Clinical features in Acute febrile 
encephalopathy
Fever Headache Vomiting
Altered sensorium Seizure Focal neurological  deficit
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RENAL FUNCTION TEST 
Table 4 BLOOD UREA LEVELS 
UREA FREQUENCY PERCENT 
<40 mg/dl 54 54.0 
>40 mg/dl 46 46.0 
Total 100 100.0 
 
Chart 4 : BLOOD UREA LEVELS 
 
 46% had raised blood urea values in our study in patients acute 
febrile encephalopathy 
 
 
 
 
59%
41%
UREA
<40
>40
TABLE
CREATININE  mg/dl
< 0.8 NORMAL
>0.9 INCREASED
Total
 
Chart 
 
Creatinine was raised 
encephalopathy patient
 
 
97%
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 5 :  BLOOD CREATININE LEVELS
 FREQUENCY PERCENT
 33 
 67 
 100 
- 5 : BLOOD CREATININE LEVELS
 in 67%  of cases in our study in 
 
 
33%
CREATININE
 
 
33.0 
67.0 
100.0 
 
 
acute febrile 
<0.8
>0.9
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TABLE 6 : BLOOD HEMOGLOBIN  VALUE 
HAEMOGLOBIN mg/dl FREQUENCY PERCENT 
6-8 3 3.0 
8.1-10 16 16.0 
10.1-12 29 29.0 
12.1-14 52 52.0 
Total 100 100.0 
 
Chart 6 : BLOOD HEMOGLOBIN FREQUENCY LEVEL 
 
          Hemoglobin was very low about 6-8 mg/dl in 3% of case with  in 
our study and 52% had  normal levels 
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TABLE 7 : Total leucocyte count 
Total leucocyte count 
(cell/mm) 
FREQUENCY NO OF CASES 
<4000 10% 10% 
4000-12000 40% 40% 
>12000 50% 50% 
 
Chart 7: Total leucocyte count 
 
  
          Total leucocyte count was raised in more90% cases in our study in 
acute febrile encephalopathy patient 
 
 
 
10%
40%
50%
No of cases
<4000 4000-12000 >12000
TABLE 
PLATELET COUNT /
> 100000
> 50000
< 20000
≤ 10000
 
  
Chart
 Platelet count
low levels and  needed blood transfusion platelet  transfusion 
in  patients with acut
 
 
 
20%
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8: BLOOD PLATELET COUNT
ΜL FREQUENCY NO OF CASES
 
 
 
 
60% 
20% 
10% 
10% 
 8 :  BLOOD PLATELET COUNT
 was reduced in 50% of cases  and 10% had very 
e febrile encephalopathy. 
60%
10%
10%
PLATELET COUNT  
 
 
60% 
20% 
10% 
10% 
 
 
in our study 
>100000
>50000
<20000
≤10000
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TABLE 9 : LIVER FUNCTION TEST 
DIRECT BILIRUBIN mg./dl FREQUENCY PERCENT 
>0.2 14 14.0 
<0.2 86 86.0 
Total 100 100.0 
 
INDIRECT BILIRUBIN mg./dl FREQUENCY PERCENT 
>0.8 20 20.0 
<0.8 80 80.0 
Total 100 100.0 
 
Chart 9. Liver Function Test 
 
 
 
 
 Liver function test was raised in 20 % of cases of  patients with 
acute febrile encephalopathy  due to hepatic complications. 
 
 
 
 
14%
86%
0%
50%
100%
>0.2 <0.2
DIRECT BILIRUBIN
>0.2
<0.2
20%
80%
0%
50%
100%
>0.02 <0.02
INDIRECT BILIRUBIN
>0.02
<0.02
MANTOUX
<10mm  
11mm+ve 
12mm+ve 
13mm+ve 
15mm+ve 
Total 
 
 Mantoux was
in of patients with tuberculosis 
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TABLE 10 : MANTOUX TEST 
 FREQUENCY PERCENT
94 
2 
1 
1 
2 
100 
Chart 10 : MANTOUX TEST 
 positive in our study in 5% cases with tuberculosis 
encephalitis 
 
94%
2%1%1%1%
MANTOUX
<10mm Normal
11mm+ve
12mm+ve
13mm+ve
15mm+ve
 
94.0 
2.0 
1.0 
1.0 
1.0 
100.0 
 
TABLE 11
Sputum Culture
Sensitivity& AFB
Mycobacteria
Sputum culture 
CHART11
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 : SPUTUM CULTURE/SENSITIVITY
/ 
 
FREQUENCY No of cases  
 5 
 
sensitivity seen in 5% cases in the study
: SPUTUM CULTURE/SENSITIVITY& AFB
5%
95%
No of cases
Mycobacteria Others
& AFB 
positive 
5% 
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TABLE 12 : BLOOD SEROLOGY 
BLOOD SEROLOGY  FREQUENCY PERCENTILE  
VIRAL   
HIV 2 2% 
HBV 2 2% 
DENGUE 3 3% 
VZV 2 2% 
SCRUB TYPHUS 6 6% 
HSV 11 11% 
LEPTOSPIROSIS 6 6% 
HAV 2 2% 
CMV 2 2% 
JE 2 2% 
EBV 2 2% 
 
Herpes simplex virus  was positive in  11%with maximum 
incidenceamong patients with positive  IgM antibodies in serum cases in 
our study in acute febrile encephalopathy patient  
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CHART 12 : BLOOD SEROLOGY  
 
 
 23% Viral  encephalopathy was most common in 28% our case 
study  
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TABLE 13 : MALARIAL PERIPHERAL SMEAR 
MALARIAL PERIPHERAL SMEAR FREQUENCY PERCENT 
Falciparum 7 7.0 
Vivax 6 6.0 
Total 100 100.0 
 
 
FIGURE 13 : MALARIAL PERIPHERAL SMEAR 
 
 Malaria was positive in 13%  cases in our study in acute febrile 
encephalopathy patient 
 
 
  
87%
7%
6%
MALARIAL PERIPHERAL  
SMEAR
NORMAL
Falciparum
Vivax
WIDAL  TEST 
WIDAL  TEST
positive 
 
 
 
 
 Widal  positive in  
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TABLE  14 : WIDAL  TEST 
 FREQUENCY PERCENTILE
8 8% 
 
CHART 14 : WIDAL  TEST 
 was 8% cases  in our case study
8%
92%
WIDAL
Widal  positive Widal  Negative
 
 
TABLE 15 
BLOOD CULTURE 
SENSITIVITY
Bacteria
Fungus
 
Mycobacteria
 
Salmonella  typhi
 
 
BLOOD CULTURE & SENSITIVITY
Streptococcus 
Staphylococcus 
Streptococcus 
Pneumococcus 
Salmonella 
Chart 15 : BLOOD CULTURE SENSITIVITY
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4%
6%
BLOOD CULTURE SENSITIVITY
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: BLOOD CULTURE SENSITIVITY
 
FREQUENCY NO OF CASES
 16 
 6 
Sputum C/S & AFB 
 5 
 
 8 
 Frequency 
6 
4 
6 
3 
3 3%
 
16%
6%
3%
3% streptococcus
staphylococcus
streptococcus
pneumococcus
salmonella
 
 
16% 
6% 
5% 
 
8% 
No Of Cases 
6% 
4% 
6% 
3% 
 
 
TABLE  16 
 
PROTEIN(mg/dl)
<40
40
>100
Sugar (mg/dl)
≤
≥
FIGURE 16 
 
0%
10%
20%
30%
40%
50%
60%
70%
<40 40-100
PROTEIN (mg/dl)
40% 40%
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: CSF PROTEIN AND SUGAR VALVES
 FREQUENCY CASES
 40 40%
-100 40 40%
 20 20%
  
40 60 60%
40 40 40%
 
: CSF PROTEIN AND SUGAR VALVES
 
>100 ≤40 ≥40
SUGAR
20%
60%
40%
 
 
 
 
 
 
 
 
 
PROTEIN (mg/dl) <40
PROTEIN (mg/dl) 40-100
PROTEIN (mg/dl) >100
SUGAR ≤40
SUGAR ≥40
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TABLE 17 : CSF  BACTERIAL GRAM STAIN POSITIVITY 
CSF  BACTERIAL GRAM STAIN POSITIVITY FREQUEN
CY 
NO OF 
CASES 
 
  
Streptocooci 4 4% 
Staphylococci 2 2% 
Mycobacteria Tuberculosis 5 5% 
Pneumococcus 5 5% 
Nesseriameningococcoi 1 1% 
Gram negative Bacilli 1 1% 
   
CSF Culture Sensitivity   
Bacteria 8 8% 
Mycobacteria 6 6% 
Fungus 1 1% 
Cryptococcus 1 1% 
 
 
CHART 17 : CSF  BACTERIAL GRAM STAIN POSITIVITY 
Bacterial meningitis was seen in 16% of cases in our study 
 
TABLE 18 : CSF 
CSF  VIRAL STUDY
Herpes simplex virus
Epstein barr virus
Cytomegalovirus
Japanesese  encephalitis virus
Varicella zoster virus
Herpes zoster virus
 
 Herpes simplex virus 
Chart 18 : CSF  VIRAL STUDY  AND CULTURE&SENSITIVITY
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 VIRAL STUDY  AND CULTURE&SENSITIVITY
 
No Of Case
 
 
 
 
 
 
was positive in 15% cases in our study
 
 
 
0% 5% 10%
mycobacteria
Fungus
2%
2%
1%
2%
5%
1%
Percentage
 
 
15% 
2% 
2% 
1% 
2% 
2% 
 
 
 
 
 
 
 
 
 
15%
15%
13%
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TABLE 19 : COMPLICATIONS IN  PATIENTS  WITH ACUTE FEBRILE 
ENCEPHALOPATHY 
COMPLICATIONS IN PATIENTS WITH ACUTE 
FEBRILE   COMPLICATIONS FREQUENCY 
Total No Of 
Patients/ 100 
IMPROVED 
COMPLETEY 
WITHOUT ANY 
COMPLICATION 
OR 
NEUROLOGICAL 
DEFICIT 
 80 80 
IMPROVED 
WITH 
NEUROLOGY 
DEFICIT 
FOCAL NEUROLOGICAL 
DEFICIT 
3 3 
VISUAL DEFICITS 2 2 
SENSORINEURAL   DEAFNESS 
FOCAL NEUROLOGICAL 
DEFICIT 
3 3 
OTHER  SYSTEM 
INVOLVEMENT 
ARF-acute renal failure 
GIT-gastrointestinal  
PNEUMONIA 
ALF-acute liver failure 
4 
4 
4 
1 
 
DEAD MODS-Multiorgan failure 
DIC-Disseminated intravascular 
coagulation 
ARDS-Acute respiratory distress 
syndrome  
 
5 
1 
3 
 
 
CHART 19 : PROGNOSIS 
 
RECOVERED COMPLETELY
FOCAL NEUROLOGICAL DEFICIT
SENSORINEURAL   DEAFNESS FOCAL 
SYSTEMIC COMPLICATIONS 
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 AND COMPLICATIONS IN PATIENTS 
WITH ACUTE FEBRILE  
 
0% 10% 20% 30% 40% 50%
VISUAL DEFICITS
…
ARF
GIT
PNEUMONIA
ALF
MODS
DIC
ARDS
3%
2%
3%
4%
4%
4%
1%
5%
1%
3%
 
60% 70% 80%
80%
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TABLE 20 : COMPLICATIONS IN PATIENTS WITH ACUTE 
ENCEPHALOPATHY  IN PATIENTS 
COMPLICATIONS IN PATIENTS WITH ACUTE 
ENCEPHALOPATHY  IN PATIENTS 
FREQUENCY NO OF CASES 
Respiratory failure 5% 5 
Psychosis 2% 2 
Peripheral circulatory failure 5% 5 
Sepsis 6% 6 
Hemiparesis 5% 5 
Quadriparesis 5% 5 
Pericardial effusion 4% 4 
Drug reaction 3% 3 
 
CHART 20: COMPLICATIONS IN PATIENTS WITH ACUTE 
ENCEPHALOPATHY  IN PATIENTS 
 
 
 
 
5% 5%
3%
6%
9%
3%
5% 5% 4% 3%
0%
2%
4%
6%
8%
10%
COMPLICATIONS IN PATIENTS WITH ACUTE 
ENCEHALOPATHY  IN PATIENTS 
Respiratory failure Psychosis
Peripheral circulatory failure Sepsis
Bleeding manifestations Bed sore
Hemiparesis Quadriparesis
Pericardial effusion Drug reaction
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TABLE 21 : GENERAL AND SYSTEMIC EXAMINATION OF  
FINDINGS IN ACUTE FEBILE ENCEPHALOPATHY 
General Examination  finding of AES FREQUENCY NO OF CASES 
Temperature(100 F) 60% 60 
Tachycardia 40% 40 
Bradycardia 6% 6 
Tachypnea 8% 8 
Anemia 25% 25 
Hypotensive shock 10% 10 
Icterus 18% 18 
Edema 10% 10 
Lymphadenopathy 5% 5 
Cyanosis 3% 3 
Clubbing 4% 4 
 
 
CHART 21 : GENERAL AND SYSTEMIC EXAMINATION OF  
FINDING IN ACUTE FEBRILE ENCEPHALOPATHY 
 
 
60%
40%
6% 8%
25%
10% 18% 10% 5% 3% 4%
0%
20%
40%
60%
80%
GENERAL EXAMINATION  FINDING OF AES 
Temperature(100 F) Tachycardia Bradycardia
Tachypnea Anemia Hypotensive shock
Icterus Edema Lymphadenopathy
Cyanosis Clubbing
TABLE 22
SYSTEMIC FINDING OF AFE 
Abdominal examination
Hepatomegaly 
Splenomegaly 
Hepatosplenomegaly
Ascites 
 
FIGURE 22 
 Abdominal examination showed
hepatosplenomegaly and ascites 5% in 
with acute febrile encephalopathy
 
8, 32%
5, 20%
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: SYSTEMIC FINDING OF AFE CASES / 
ABDOMINAL EXAMINATION 
 
 PERCENTILE
 
 
5% 
7% 
 8% 
5% 
:  SYSTEMIC FINDING OF ABDOMINAL 
EXAMINATION 
 8% 
of cases in our study in  patients 
 
 
5, 20%
7, 28%
SYSTEMIC FINDING OF AFE CASES ABDOMINAL 
EXAMINATION
Hepatomegaly
Splenomegaly
Hepatospleenomegaly
Ascites
 
 
NO OF 
CASES 
 
5 
7 
8 
5 
 
cases with  
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TABLE 23 : LDH IN SERUM 
LDH IN SERUM 
NORMAL 140-280 (IU/L) 
FREQUENCY PERCENT 
390 1 1.0 
450 7 7.0 
>550-1000 13 13.0 
>1050-1590 8 8.0 
NO OF CASES TOTALLY INCREASED IN  29 29.0 
NORMAL 71 71.0 
Total 100 100.0 
 
CHART 23 : LDH IN SERUM 
 
 
 
 Lactate dehydrogenase (LDH) levels raised in 28% cases in our study 
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DISCUSSION 
 AGE - In our study  35% cases of acute febrile encephalopathy 
most common in age group between 21-30 years 
 
 SEX - Male patients were more common  in our study group  about 
59% 
 
 ETIOLOGY-Viral aetiology of encephalopathy was more  
common in  28%,  bacterial meningitis was seen in 16% cases of 
our study. 
 
 CLINICAL FEATURES - Headache  55% and fever 40% were the 
most common clinical manifestations. Neck rigidity 34 %,altered 
sensorium 37%, seizures 24% & focal neurologicial deficit   9 % 
was  least common  
 
 SYSTEMIC EXAMINATION Abdominal examination showed  
8% cases with  hepatosplenomegaly and 5% with ascites in of 
cases in our study in  patients with acute febrile encephalopathy 
 
 RENAL PARAMETERS - 46% had raised  blood urea values in 
our study in patients with acute febrile encephalopathy, Creatinine  
was raised  in 67%  of cases in our study. 
 
 COMPLETE BLOOD COUNT - Hemoglobin was  very low about 
6-8 mg/dl in 3% of case with  in our study and 52% had normal 
levels,Total leucocyte count was raised in morethan90% cases   in 
our study in acute febrile encephalopathy patients 
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 PERIPHERAL SMEAR STUDY-Malaria was positive in 13%  
cases in our study 
 
 WIDAL TEST - Widal  positive   was 8% cases  in our case study 
 
 CSF ANALYSIS  - 23% Viral  encephalopathy was most common 
in our case study  
 
 PROGNOSIS - Most of the patients recovered with good prognosis 
focal neurological deficit was seen in 3% of patients. 80% of the 
patients recovered with good prognosis. Focal neurological deficit 
was seen in 3% of patients LDH levels raised in serum in 28 % of 
cases in our study suggestive of infectious etiology 
 
 COMPLICATIONS - Respiratory system 5% ,peripheral shock  
3%,sepsis, 6%,bleeding 9% 
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CONCLUSION 
 Acute febrile encephalopathy is most common in age group 
between 21-30 yrs 
 
 Male patients were more common 
 
 Viral   aetiology   was more  common cause of acute febrile 
encephalopathy and other aetiology  like protozoal, fungal were 
rarely identified causes  
 
 Headache and fever were the most common clinical manifestations. 
 
 Raised  blood urea, Creatinine values seen in few  patients 
 
 CSF analysis showed 23% Viral  encephalopathy was most 
common cases  
 
 Overall the Patients recovered with good prognosis 
 
  
  
 
 
SUMMARY 
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SUMMARY 
 Viral   aetiology   was more common cause of acute febrile 
encephalopathy and other aetiology like protozoal, fungal were rarely 
identified causes. Males were more commonly affected. Headache   
and fever were the most common clinical manifestations, neck 
rigidity, altered sensorium, seizures, focal neurologicial deficit was  
least common 
 Viral  encephalopathy was most common in  our case study 
 
 Septic encephalopathy was second  most common  
 
 Most of the patients recovered with good prognosis and few 
complication 
 
 Most  common  cause was viral meningitis-  
 
 Herpes  encephalitis, bacterial meningitis, cerebal malaria, 
tubercular meningitis, sepsis associated encephalopathy, 
typhoid encephalopathy, protozoal meninigitis were also seen   
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THE LIMITATION OF THE STUDY 
The limitation of the study were lack of estimation and  
CSF - DNA PCR estimation due to non availability. 
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ANNEXURES 
  
INFORMATION SHEET 
We are conducting a study on 
“A STUDY ON ETIOLOGY, CLINICAL FEATURES, DIAGNOSIS 
AND PROGNOSIS IN ACUTE FEBRILE ENCEPHALOPATHY”   
 among patients attending Rajiv Gandhi Government General Hospital, 
Chennai and for that your specimen may be valuable to us. 
The purpose of this study is  
1. Etiology clinical features, diagnosis and prognosis of patients with  
acute febrile encehalopathy. 
2. Procedure all patient with febrile acute encephalopathy will be 
examined and evaluated for routine  fever blood investigations ,if 
needed lumbar puncture will be done and CSF analysis will be 
done for viral serology ,CT scan if needed MRI scan will be done 
We are selecting certain cases and if you are found eligible, we 
may be using your information which in any way do not affect your final 
report or management. 
The privacy of the patients in the research will be maintained 
throughout the study. In the EVENT of any publication or presentation 
resulting from the research, no personally identifiable information will be 
shared. 
Taking part in this study is voluntary. You are free to decide 
whether to participate in this otherwise entitled. 
The results of the special study may be intimated to you at the end 
of the study period or during study or to withdraw at any time; your 
decision will not result in any loss of benefits to which you are doing the 
study if anything is found abnormal which may aid in the management or 
treatment. 
 
Signature Of Investigator    Signature of Participant 
 
Date: 
Place 
  
 
PATIENT CONSENT FORM 
Study Detail : “A STUDY ON ETIOLOGY, CLINICAL FEATURES, 
DIAGNOSIS  AND PROGNOSIS IN ACUTE FEBRILE 
ENCEPHALOPATHY”   
 
Study Centre : Rajiv Gandhi Government General Hospital, Chennai. 
Patient’s Name :  
Patient’s Age :  
In Patient Number :  
Patient may check (☑) these boxes 
I confirm that I have understood the purpose of procedure for the above study. I 
have the opportunity to ask question and all my questions and doubts have 
been answered to my complete satisfaction. 
 ❏ 
I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time without giving reason, without my legal rights being 
affected. 
 
I understand that lumbar puncture will be done and  CSF analysis will be done.8 
ml venous blood will be drawn and  given for investigation CT scan & MRI scan  
if needed will be done 
 ❏ 
I understand that sponsor of the clinical study, others working on the sponsor’s 
behalf, the ethics committee and the regulatory authorities will not need my 
permission to look at my health records, both in respect of current study and 
any further research that may be conducted in relation to it, even if I withdraw 
from the study I agree to this access. However, I understand that my identity 
will not be revealed in any information released to third parties or published, 
unless as required under the law. I agree not to restrict the use of any data or 
results that arise from this study. 
 ❏ 
I agree to take part in the above study and to comply with the instructions given 
during the study and faithfully cooperate with the study team and to 
immediately inform the study staff if I suffer from any deterioration in my 
health or well being or any unexpected or unusual symptoms ❏ 
I hereby consent to participate in this study 
 
❏ 
 
I hereby give permission to undergo complete clinical examination and diagnostic 
tests including hematological, biochemical, radiological tests. ❏ 
 
 
Signature / thumb impression / parents     Signature of Investigator / Study /  
Patient’s / parents Name and Address  Investigator’s Name: 
             Dr.JOTHILAKSHMI.V. 
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F mg/dl cell/mm meq/dl meq/dl SGOT direct indirect mm
1 14 M + + + + + 100 13 8000 50000 30 0.9 mg/dl mg/dl
2 45 F + + + + petechia 103 14 1000 100000 26 0.8 0.02 0.2 IgM+
3 34 M + 99 12 3000 250000 30 1.1 0.03 0.8
4 35 M + + + + 99.9 14 34000 20000 34 0.8 0.13 0.6 IgM+
5 15 M + + 100 10 23000 45000 13 0.9 250 1 0.8 HAV
6 26 F + + 104 13 300000 40 1.2 0.02 0.9
7 36 M + + + + Eschar 101 14 4000 430000 30 0.89 0.03 0.8 IgM+
8 32 M + + ++ 8.6 4500 L 340000 26 0.86 0.9 4.5
9 38 F + + + + + + 102 9.9 5000 230000 30 0.9 2 1 IgM+
10 27 M 12.5 6500 210000 39 1 0.05 0.6
11 18 M + + 11.7 150000 23 1.1 0.03 0.4
12 34 M + + + + + 102 9 3000 14000 500 34 0.9 30 0.043 0.3 HIV IgM+
13 24 F + + 103 6.7 12000 p 23000 39 1.2 0.014 0.2 IgM+
14 34 F + + + + + 8.9 13000 p 43000 36 0.98 0.04 0.6
15 45 M + 10.1 240000 346000 29 0.876 0.053 1.2
16 34 F + + + + 11.8 5000 245000 29 0.9 0.04 1.3
17 23 F 13.2 4000 23000 36 1.1 3 1 IgM+
18 34 M + + Vesicles 14 7000 L 340000 40 1.5 0.02 0.2 11mm+VE
19 23 M + 101 13.8 12000 21500 50 2 0.01 0.6 VZV
20 45 F + + 11.3 5000 34000 68 1.5 0.02 0.2
21 35 F 101 12.2 12000 45000 50 1.3 0.05 0.4
22 48 M + + 14 4000 p 234500 40 1.1 0.035 0.6
23 26 M + + 13.5 3000 23100 28 0.9 0.04 0.2
24 17 F + + + + 99.9 8.9 2000 16000 30 1.9 0.9 1.2 IgM+
25 24 M + petechia+ 100 11.9 4000 32000 90 35 1.2 0.34 0.7 HIV
26 34 M + 12.5 4500 45000 40 1.2 0.45 0.23
27 25 M + + + 101 13.1 2500 320000 28 1.1 0.9 2 IgM+
28 19 M + + + + + 100 13 15000 54000 40 1.1 0.01 0.2
29 23 F + + 10.5 20000 P 60000 58 1.3 0.03 0.5
30 45 M + + + 12.6 24000 320000 30 1.1 0.03 0.1
31 16 M + + 13.3 4000 203000 45 0.8 450 0.08 0.3 HBV
32 35 M + + + + + + 102 12.9 25000 45000 50 3 0.7 0.4
33 31 F Eschar 10.5 2000 23560 100 12 0.06 0.5 IgM+
34 35 F + + + 10.9 3400 365000 30 0.9 0.09 0.4
35 45 M + + + 101 12.5 3000 40000 34 1 1 0.9 IgM+
36 25 M + 13 12000 23340 67 2 0.04 0.2
37 45 M + + + + 12.5 23000 210000 35 1.1 0.05 0.1
38 36 F + + ++ 10.3 5500 125000 30 1 0.08 1 12mm+ve
39 28 F + 9.9 2300 348900 45 1.2 0.08 0.8
40 40 M + 102 12.6 10000 P 245300 45 1.5 1 0.3
41 19 M + + 101 9.7 2400 342500 45 1 0.09 3
42 43 F + + + + + 10.5 3000 56000 30 0.89 0.04 0.5
43 31 F + + 11.5 4000 54000 34 0.9 0.07 0.7
44 35 M 13.4 5000 145000 45 1 0.05 0.3
45 18 M + + + + + + 13.7 35000 P 245800 40 1 0.02 0.8
46 17 M + 14 23000 234500 30 0.8 0.08 0.7
47 36 F + + + + + 8.6 14000 L 345060 123 14 0.03 0.6 15mm+VE
48 16 F + + + petechia+ 104 10.3 3800 23410 34 1 1 0.9 IgM+
49 15 M + + 13.7 14000 L 45000 25 0.9 0.07 2 HAV
50 31 M + 101 12 4500 345000 27 0.9 0.02 4 13mm+ve
51 24 M + + + + 100 10.4 3800 243500 34 1.1 0.05 0.1
52 34 F 13 3450 34500 26 0.9 0.03 0.2
53 25 F + Eschar 11 70000 234100 74 3 0.05 0.2 IgM+
54 34 M + + 12.6 2345 P 234500 80 4 0.05 0.1
55 17 M + + 100 12.1 5600 L 45630 24 0.9 0.03 0.6
56 26 F + 101 10.9 14500 34500 54 2.5 0.02 2.3
57 19 F + + + + + 100 9.9 13000 25000 32 1.2 0.07 4.3 IgM+
58 21 M + + + 11.6 4530 45000 54 1.5 0.04 0.7
59 24 M 13 5400 P 234500 32 0.9 0.03 0.9
60 32 F + 10.8 2300 124500 134 10 0.06 0.5
61 29 F + + + + + + Vesicles 9.6 3450 23450 54 1.5 0.45 0.3 VZV
62 16 M + 102 10.4 12350 12500 23 0.9 0.08 4 IgM+
63 15 M + + + + + 12.7 5400 234100 45 1.6 0.067 0.8
64 26 F 102 10.5 12000 L 456300 L 65 2.5 0.04 0.8
65 34 M + + + + 13.5 5400 234500 29 0.9 0.09 0.2
66 32 M + + 102 12.5 13500 123450 69 3 0.05 4 IgM+ IgM+
67 17 M + + + + + 99 13.6 2340 32450 25 0.9 0.08 0.8
68 28 F + + + + + 10.6 4500 245000 45 2 0.07 0.3
69 45 M + 101 13 12350 234105 25 0.89 0.02 3
70 29 M + 10.7 3450 25000 19 0.7 0.04 5 IgM+
71 18 F + + + + + 100 13.5 12000 L 150050 26 0.76 0.03 0.2 11mm+ve
72 32 F + 13.6 3450 354250 54 3 0.05 0.4
73 39 M + + 103 11.8 5430 L 345200 43 2 0.04 0.3
74 35 M ++ 12.6 13500 354290 54 3.5 0.01 0.8
75 17 M + Eschar 9.8 5430 234500 32 1.2 0.05 0.2 IgM+
76 23 F + + + + 12 4530 23450 43 1.5 0.03 0.4
77 31 M + + + 12.6 3240 23450 73 4 0.08 0.3
78 38 M + + + + + + 101 12.6 12450 P 34500 35 0.9 0.05 3
79 17 F 11.6 5640 14500 63 2.6 0.07 0.5
80 19 M + + + + + 100 14 4500 345000 34 1.1 0.04 0.9
81 20 M + 102 13.7 13000 324500 28 0.87 0.06 2.3 IgM+
82 35 F + + + + 11.1 6000 32100 24 0.76 0.03 0.3
83 24 F 6.6 5600 23150 65 3.6 0.03 0.7
84 18 M + + + + + 10.9 4530 345200 190 14 0.03 0.3
85 14 F + + + + 101 8.9 13500 P 24000 40 13 0.05 0.5 15mm+ve IgM+
86 25 F + + + 9.7 5765 L 25640 36 0.9 0.9 2
87 34 M 104 11.9 25000 254600 45 3 0.06 0.1
88 32 F + + 102 8.7 35000 354200 69 4.5 0.07 0.3
89 24 M 101 13.1 23000 235100 45 3 0.01 0.4
90 18 M + + + 102 12.8 2345 34500 123 15 0.05 3
91 34 F + + + + + + 6 1000 P 43500 89 8 1 0.9 HIV
92 35 F + 12.5 7860 89000 34 0.9 0.04 0.3
93 23 M + + 99.9 k 14.1 6540 356400 23 0.8 0.06 0.2
94 17 M + ++ + 13.9 5630 254300 34 1.4 0.03 0.1
95 14 M + + + + + + 104 14.1 5640 P 34500 65 4 0.08 3 IgM+
96 15 F + + + 13.6 6700 453200 40 2 0.06 0.4
97 18 M 12.7 14000 45300 60 3 0.08 0.5 IgM+
98 18 M + + ++ ++ + + Eschar 103 13.5 2340 345000 34 2 0.07 3
99 20 F 101 13.3 5600 P 345600 39 2.5 0.04 0.4
100 14 F + + + + 10 3000 100000 30 0.8 4 0.2 HBV
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sugar protein LDH ADA WBC P/L
mg/di mg/dl cell/ϰL
+
+ HSV+
+
450
falciparum 34 70 Streptococcus GM+ve
mycobacteria + + 1250 20 100 110 16 100 L-550 TB
600 IgM+
+ 135 + + HSV+
30 60 1020
+ 1200 IgM+ CMV+
30 200 96 145 P-550 pneumococcus GM-ve
streptococcus 1250
staphylococcus 1257 25 65 1050
IgM+ve
+ HSV+
890 120 mycobactrium +
650 20 186 100 1050 P-500 Streptococcus GM+ve
+ HSV+
falciparum 45 74 50 150 + HSV+
streptococcus
IgM+ JE+
+ + HSV+
450 25 89 106 250 p-590 cryptococcus india ink +
1430 30 64 112 11 1000 L 450 mycobacterium TB
streptococcus 1590
pnuemocococcus 28 80 1200
+
250 + HSV+
falciparum 550 10 120 106 678 P-650 staphlococcous GM+ve
40 70 40 80 IgM+
45 150 39 450
+
+ HSV+
mycobacteria + 1050 30 130 L 650
TB
streptococcus 450 20 90 +
vivax 25 150 1200 P-550 streptococcus GM+ve
+
35 85 IgM+
streptococcus 550 25 80 65 135 + HSV+
+ salmonella
mycobacteria + 1450 10 200 100 130 L 500 mycobacterian TB+
*
450 20 400 120 12 765 L 450 mycobacterium TB+
vivax
550 10 250 90 2000 P-560 pneumococcus GM-ve
+
850 20 290 96 streptococcus GM+ve
streptococcus + HSV+
1590 15 300 130 16 mycobacterium TB+
falciparum
650 25 269 98 1400 streptococccus GM+ve
staphylococcus 550
+
45 150 100 100 P-800
650 40 75 120 pneumococcus GM-ve IgM=+
+ streptococcus +
+falciparum
450 15 300 100 145 P-650 neisseria GM-ve +
550 10 450 jj 1430 P-550 pneumococus GM-ve +
1345 20 300 550 70 980 L 450 mycobacterium + TB+
pneumococcus 550
+
falciparum salmonella 390
+
650 24 295 1350 P-450 streptococcus GM+ve
45 75 IgM+ve CMV+
+ +
450 75
mycobacteria pneumococcus 1560 18 450 mycobacterium + TB+
+
+
650 30 290 234 950 P-650 staphlococcus GM+ve
falciparum
+
mycobacberia +
Rabies +
staphlococcal 450 30 76 P-200 pnemococcus GM-ve +
+
vivax
salmonella 450 35 45 P-250
25 200 150 P-350
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Odema Focal HYDROCEPHALUSTUBERULOMA Focal Basal exdudate DIFFUSE MRS IMPROVEDNEURODEFICIT DEAD
+
visual D
+ + + ARDS
Temperoparital +
REL REL neurocysticersosis GIT
+ D MODS
+ subdural effusion focal
+
tuberuloma+ SNHL
+ + +
+ + Leptomenigitis
temperoparital +
REL
+ D MODS
+ + + + + tuberculoma
GIT
+
REL neurocystecercosis
+ Leptomenigitis Abscess REL abcess focal ARF
ARF
++ + D MODS
ARF
+ +
+ RS
+
+ Subdural effusion + REL abscess
SNHL
+ neurocysticecosis
++ D DIC
+
+
+ +
+ +
+
+ REL Abscess
+
+ Leptomenigitis Abscess
+
+ + + + REL
+ + BLURRING VISION
++ D ARDS
ARF
+
+ + REL Abscess
+
++ D MODS
+ +
visual D
+ + +
Pneumonia
Meningitis SHNL
++
+
Abscess +
+
DIFFUSE
+ tuberculoma RS
+ meningitis Abcess + bluring of vision
+
meningitis + focal D MODS


